We are live on
!
Find out more
AJ
Ashburton (Jersey) Portfolio holdings
AUM
$227M
This Fund
S&P 500
This Quarter
Est. Return
+5.74%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
-$9.72M
(-4%)
Cap. Flow
-$2.24M
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
79.91%
Holding
86
New
21
Increased
25
Reduced
12
Closed
15
Avg Time Held
4.6
quarters
Top 10 Avg Time Held
8.1
quarters
Top 20 Avg Time Held
4.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$11.7M |
| 2 |
Medtronic
MDT
|
+$9.73M |
| 3 |
HDFC Bank
HDB
|
+$4.6M |
| 4 |
Philip Morris
PM
|
+$2.08M |
| 5 |
Occidental Petroleum
OXY
|
+$1.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$24.9M |
| 2 |
MON
Monsanto Co
MON
|
+$4.96M |
| 3 |
RSPP
RSP Permian, Inc.
RSPP
|
+$1.52M |
| 4 |
Anadarko Petroleum
APC
|
+$1.28M |
| 5 |
Diamondback Energy
FANG
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Financials | 20.42% |
| 3 | Technology | 18.08% |
| 4 | Communication Services | 11.93% |
| 5 | Consumer Staples | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.97T
| $27.3M | 11.81% |
277,258
-3,252
| -1% | -$315K |
2015 Q4
10 quarters
|
|
2
Visa
V
$724B
| $23.8M | 10.27% |
179,411
-5,071
| -3% | -$653K |
2015 Q4
10 quarters
|
|
3
Alphabet (Google) Class C
GOOG
$4.25T
| $22.9M | 9.88% |
410,000
+5,920
| +1% | +$320K |
2015 Q4
10 quarters
|
|
4
Merck
MRK
$359B
| $19.1M | 8.26% |
330,117
+5,539
| +2% | +$312K |
2015 Q4
10 quarters
|
|
5
Home Depot
HD
$290B
| $18.6M | 8.04% |
95,353
-193
| -0.2% | -$36.1K |
2015 Q4
10 quarters
|
|
6
Johnson & Johnson
JNJ
$630B
| $17.7M | 7.64% |
145,725
+8,196
| +6% | +$1.02M |
2015 Q4
10 quarters
|
|
7
JPMorgan Chase
JPM
$885B
| $17.4M | 7.53% |
167,223
-5,013
| -3% | -$550K |
2015 Q4
10 quarters
|
|
|
8
Philip Morris
PM
$314B
| $16.3M | 7.05% |
202,106
+24,525
| +14% | +$2.08M |
2015 Q4
10 quarters
|
|
9
Adobe
ADBE
$94.3B
| $12.9M | 5.58% |
52,946
+1,081
| +2% | +$256K |
2017 Q3
3 quarters
|
|
10
The Kraft Heinz Company
KHC
$26.4B
| $8.96M | 3.87% |
142,638
+5,091
| +4% | +$302K |
2017 Q4
2 quarters
|
|
|
11
HDFC Bank
HDB
$115B
| $4.83M | 2.09% |
+184,000
| New | +$4.6M |
2018 Q2
0 quarters
|
|
12
CVS Health
CVS
$110B
| $3.9M | 1.68% |
60,597
+1,711
| +3% | +$113K |
2015 Q4
10 quarters
|
|
|
13
Medtronic
MDT
$113B
| $2.84M | 1.23% |
+116,499
| New | +$9.73M |
2018 Q2
0 quarters
|
|
14
Pfizer
PFE
$161B
| $1.99M | 0.86% |
57,753
+458
| +0.8% | +$15.7K |
2016 Q3
7 quarters
|
|
15
Suncor Energy
SU
$84.5B
| $1.92M | 0.83% |
47,169
+21,000
| +80% | +$818K |
2017 Q4
2 quarters
|
|
16
AT&T
T
$152B
| $1.57M | 0.68% |
64,850
+17,655
| +37% | +$443K |
2016 Q3
7 quarters
|
|
17
DELISTED
WildHorse Resource Development
WRD
| $1.5M | 0.65% |
58,954
| – | – |
2017 Q3
3 quarters
|
|
|
18
Occidental Petroleum
OXY
$60.1B
| $1.47M | 0.64% |
+17,600
| New | +$1.41M |
2018 Q2
0 quarters
|
|
19
Chord Energy
CHRD
$7.74B
| $1.47M | 0.63% |
113,180
-39,600
| -26% | -$451K |
2018 Q1
1 quarter
|
|
20
Tenaris
TS
$28.9B
| $1.45M | 0.63% |
39,948
+18,000
| +82% | +$667K |
2017 Q3
3 quarters
|
|
21
Chevron
CVX
$416B
| $1.43M | 0.62% |
11,335
-8,800
| -44% | -$1.09M |
2015 Q4
10 quarters
|
|
22
Amazon
AMZN
$2.83T
| $1.39M | 0.6% |
16,300
+2,400
| +17% | +$190K |
2015 Q4
10 quarters
|
|
23
DELISTED
Marathon Oil Corporation
MRO
| $1.35M | 0.58% |
64,784
+33,100
| +104% | +$653K |
2017 Q3
3 quarters
|
|
|
PE
24
DELISTED
PARSLEY ENERGY INC
PE
| $1.28M | 0.55% |
42,200
| – | – |
2015 Q4
10 quarters
|
|
25
Devon Energy
DVN
$53.1B
| $1.13M | 0.49% |
+25,700
| New | +$996K |
2018 Q2
0 quarters
|
|
Similar funds
AA
LHR
MWS
HPFG
KC
SL
GWM
QS
Ashburton (Jersey)'s Q2 2018 Portfolio in Review
As of Q2 2018, Ashburton (Jersey) held 86 positions worth $231M, down 4% from $241M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Ashburton (Jersey)'s Q2 2018 filing shows 21 new, 25 increased, 12 reduced and 15 closed positions. Its largest new stake was Allergan plc: 72,971 shares worth $981K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $24.9M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- Ashburton (Jersey)'s largest Q2 2018 buy was Allergan plc: 72,971 shares worth $981K.
- Ashburton (Jersey) added most to Philip Morris in Q2 2018, an estimated $2.08M increase.
- Ashburton (Jersey)'s biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $24.9M.
- Ashburton (Jersey) fully exited Monsanto Co in Q2 2018, selling an estimated $4.96M.
- Ashburton (Jersey)'s ten largest holdings make up 80% of its $231M portfolio in Q2 2018.
- Ashburton (Jersey) opened 21 new positions and closed 15 in Q2 2018.
- Ashburton (Jersey)'s portfolio value fell 4% quarter-over-quarter to $231M.
Based on Ashburton (Jersey)'s 13F filing for Q2 2018, filed 6 Sep 2018.